Advertisement
Original Contribution
JAMA. 1978;239(26):2766-2768. doi: 10.1001/jama.1978.03280530030016

Carcinoma of the Lung and Cigarette Smoking

Effect on Serum Ribonuclease Activity

  1. Dalia Maor, MSc, PhD;
  2. Michael E. Klein, MD;
  3. Daniel E. Kenady, MD;
  4. Paul B. Chretien, MD;
  5. Michael R. Mardiney Jr, MD
  1. From the Section of Immunology and Cell Biology, Baltimore Cancer Research Center, Baltimore (Drs Maor, Klein, and Mardiney), and the Section of Tumor Immunology, Surgery Branch, National Cancer Institute, Bethesda, Md (Drs Kenady and Chretien).

Abstract

Serum ribonuclease levels were determined in 54 patients with lung carcinoma, 74 long-term cigarette smokers, and 172 nonsmokers. The mean serum ribonuclease level was significantly higher in patients with lung carcinoma and long-term smokers compared with healthy nonsmokers (P<.001). The serum ribonuclease activity level was not related to chronological age, sex, or race of the smoker or nonsmoker population. Forty (75%) of 53 patients with lung cancer and 49 (66%) of 74 smokers had elevated serum ribonuclease levels compared with 13 (7%) of 179 nonsmoker healthy controls (P<.001). The highest incidence of elevation was noted in patients with epidermoid carcinoma (95%).

(JAMA 239:2766-2768, 1978)

Footnotes

  • Reprint requests to Howard County Doctor's Bldg, 9380 Baltimore National Pike, Ellicott City, MD 21043 (Dr Mardiney).

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals